Ex vivo modifiable medicament release-substance
    54.
    发明申请
    Ex vivo modifiable medicament release-substance 审中-公开
    离体可改性的药物释放物质

    公开(公告)号:US20100068256A1

    公开(公告)日:2010-03-18

    申请号:US12387311

    申请日:2009-04-29

    IPC分类号: A61K9/127 A61K9/10

    摘要: A described final dosage form includes a substance carrying a medicament in a first medicament-release state having a first bioavailability. The substance is modifiable ex vivo by an exposure to a first stimulus to carry the medicament in a second medicament-release state having a second bioavailability. The substance is modifiable ex vivo by an exposure to a second stimulus to carry the medicament in a third medicament-release state having a third bioavailability. The final dosage form includes another substance carrying another medicament in another first medicament-release state having another first bioavailability. The another substance is modifiable ex vivo by an exposure to another first stimulus to carry the another medicament in another second medicament-release state having another second bioavailability. The another substance is modifiable ex vivo by an exposure to another second stimulus to carry the another medicament in another third medicament-release state having another third bioavailability.

    摘要翻译: 所描述的最终剂型包括携带具有第一生物利用度的第一药物释放状态的药物的物质。 该物质可以通过暴露于第一次刺激而离体修饰,以使药物在具有第二生物利用度的第二药物释放状态下携带。 该物质可通过暴露于第二刺激物离体修饰以携带具有第三生物利用度的第三药物释放状态的药物。 最终剂型包括在另一第一药物释放状态下携带具有另一第一生物利用度的另一药物的另一物质。 另一种物质可以通过暴露于另一种第一刺激离体来修饰,以携带具有另一第二生物利用度的另一第二药物释放状态的另一种药物。 通过暴露于另一第二刺激物,另一种物质可以通过暴露于另一种第二刺激来进行修饰,从而将另一种药物置于具有另一种第三生物利用度的另一种第三药物释